INTRODUCTION
The secretory pathway has been the focus of considerable attention in recent years (Rothman and Orci, 1992) . In particular, the molecular machinery by which proteins are transported from the endoplasmic reticulum (ER) to and through the Golgi apparatus has been studied in detail. Less information is available about the transport of lipids along the secretory pathway (Pagano, 1990; Wattenberg, 1990; Moreau et al., 1991; Puoti et al., 1991) . As a prerequisite for studying lipid transport through the ER-and Golgi apparatus, biochemical markers for each compartment are required. Thus, we have recently shown that two sphingolipids are synthesized at discrete locations along the secretory pathway. Glucosylceramide (GlcCer), the precursor of complex glycosphingolipids such as gangliosides, is synthesized by the glucosylation of ceramide at the cytosolic surface of a preor early Golgi apparatus compartment (Futerman and Pagano, 1991) . Sphingomyelin (SM), a major component of plasma membranes, is synthesized by the transfer of phosphocholine from phosphatidylcholine to ceramide at the lumenal surface of the cis and medial Golgi apparatus (Futerman et al., 1990) .
Surprisingly, the site of synthesis of ceramide, a key intermediate in sphingolipid metabolism, has never been rigorously determined. An early study examining the site of acylation of sphingoid bases using subcellular fractions from mouse brain (Morell and Radin, 1970) suggested that ceramide synthesis occurs in mieosomes, but no attempts were made to distinguish between the various membranes that co-purify in a microsomal fraction. Another study using rat liver fractions (Walter et al., 1983) suggested that ceramide synthesis occurs in the ER, but the levelS of synthesis in either the ER or other subcellular fractions were not quantified, and no evidence concerning the topology of ceramide synthesis was presented. In the current report, using well-characterized subcellular fractions from rat liver (Futerman et al., 1990; Futerman and Pagano, 1991) , and using an assay of reaction time. The distribution of dihydroceramide synthesis was found to exactly parallel that of an endoplasmic reticulum (ER) marker upon subfractionation of microsomes, and no endogenous activity was detected in either purified Golgi apparatus or plasma membrane fractions. Limited protease digestion demonstrated that sphinganine N-acyltransferase is localized at the cytosolic surface of intact ER-derived vesicles. These results are discussed with regard to the subsequent transport of (dihydro)-ceramide from the ER to sites of further metabolism in a preGolgi apparatus compartment and in the cis and medial cisternae of the Golgi apparatus.
ceramide synthesis which does not require detergents either to disperse the substrates or incorporate them into membranes, we demonstrate that acylation of the sphingoid long-chain base occurs at the cytosolic surface of the ER, with no endogenous synthesis occurring in either a pre-Golgi apparatus compartment or in the Golgi apparatus. These results are discussed with regard to the transport of sphingolipids along the secretory pathway.
MATERIALS AND METHODS Materials
Rats (Wistar) were obtained from the Weizmann Institute Breeding Centre. NaB3H4 (9-11 Ci/mmol) was from either Du Pont-New England Nuclear or from Amersham Corp. UDP-[4,5-3H]Gal (34 Ci/mmol) was from Du Pont-New England Nuclear. Fumonisin B1 was a generous gift from Dr. A. Merrill (Department of Biochemistry, Emory University School of Medicine, Atlanta, GA, U.S.A.). Silica gel 60 plates were from Merck. The following chemicals were from Sigma Chemical Co. (St. Louis, MO, U.S.A.): sphinganine (DL-erythro-2-amino-1,3-octadecanediol); sphingosine (trans-D-erythro-2-amino-4-octadecene-1,3-diol); N-palmitoyl-DL-dihydrosphingosine; ceramide (from bovine brain); N-palmitoyl-D-sphingosine; palmitoyl CoA; stearoyl CoA; arachidonyl CoA; fatty acids, even-carbon straight chains; defatted BSA; Pronase. Chymotrypsin (CDI grade) was from Worthington. Solvents (analytical grade) were from Bio-Lab Laboratories Ltd., Jerusalem, Israel. Preparation of [4,5-3H] 
sphinganine
The structures of the sphingolipids referred to in this study are shown in Figure 1 . The long-chain sphingoid base, sphinganine, was labelled by reduction of D-erythro-sphingosine (Figure la) with NaB3H4 according to the method originally described by Schwarzmann (1978) , in which lysogangliosides were hydro- Figure 1 The structure of sphingoid bases and ceramides Structures are as follows: (a) sphingosine, (b) [4,5-3H] sphinganine ([4,5-3H] 
genated at the sphingosine double bond with tritium gas generated in situ using Pd2+ as a catalyst. Briefly, 5-10 mg of sphingosine and 1.7 mg of PdCl2 were dissolved in tetrahydrofuran in a screw-capped vial. NaB3H4 (100 mCi) was dissolved in diethyleneglycol dimethyl ether and added immediately to a screw-capped vial. After flushing with N2, the reaction was allowed to proceed for 3-4 h at room temperature with stirring. Sphingolipids were extracted into diethyl ether, dried under N2 and purified by t.l.c. with silica gel 60 plates using the following solvents: (1) CHC13/CH3OH/H20 (65:25:4 Figure Id 
Subcellular fractionation
An intact Golgi apparatus fraction (Bergeron et al., 1982) , a microsomal subfractions (Ehrenreich et al., 1973) were prepared exactly as described previously (Futerman et al., 1990) . To prepare the microsomal subfractions, microsomes were fractionated on a discontinuous sucrose gradient and the following fractions collected: light Golgi subfraction (fraction 1); intermediate Golgi subfraction (fraction 2); heavy Golgi subfraction (fraction 3); light smooth vesicles (fraction 4); heavy vesicles (fraction 5); rough microsomes (fraction 6) (Futerman and Pagano, 1991) .
Measurement of dihydroceramide synthesis in liver fractions
Defatted-BSA-sphinganine-[4,5-3H]sphinganine complexes were prepared as described for other lipids (Pagano, 1989) [4,5-3H] dihydroceramide in the organic and aqueous phases of the extraction procedure (Bligh and Dyer, 1959) . (2) Degradation of [4,5- 3H]sphinganine and [4,5-3H]dihydroceramide. Previous studies (Wang et al., 1991) have demonstrated that long-chain bases decompose in acid and base, and that this decomposition is accelerated on glass surfaces (Merrill and Wang, 1992 ). In the current study, the amount of the decomposition product present varied between 5 and 20% of the initial [4,5-3H]sphinganine added. No change in the amount of the decomposition product was seen during different times of incubation, but the amount of decomposition product was directly proportional to the amount of [4,5-3H] 
Protease treatment of microsomes
Microsomes (prepared as above except that 20 mM Hepes, pH 7.4, was included at all stages including the initial homogenization) were incubated with various amounts of either chymotrypsin or Pronase in a final volume of 280 ,ul containing 0.25 M sucrose, 20 mM Hepes, pH 7.4, and 0.1 mM (NH4)6Mo7O24,4H20 (Van Veldhoven and Mannaerts, 1991) , in either the presence or absence ofTriton X-100 [final concentration 0.2 % (v/v)] for 20 min at 30 'C. Reactions with Pronase also included 0.5 mM CaCl2. The reactions were terminated by dilution of the samples 6-fold in ice-cold homogenization buffer that included 1 mM phenylmethanesulphonyl fluoride, 1 ug/ml leupeptin, 1 jug/ml antipain and 100 k-i.u./ml aprotonin, and in the case of Pronase, 1.5 mM EGTA. Microsomal integrity after incubation with or without proteases was examined by measuring the latency of mannose-6-phosphatase (Van Veldhoven and Mannaerts, 1991) , and dihydroceramide synthesis was measured as described above.
Miscellaneous procedures
Protein concentrations, and galactosyltransferase, alkaline phosphodiesterase and glucose-6-phosphatase activities were measured as described (Futerman et al., 1990) .
RESULTS

Characterization of dihydroceramide synthesis In microsomes
Recent experiments (Merrill and Wang, 1986) supported earlier observations (Ong and Brady, 1973 ) that the 4-trans double bond of sphingolipids is added after acylation of the sphingoid base [reviewed in Merrill and Jones (1990) ]. Thus, to determine the site of acylation of the sphingoid base of sphingolipids, we examined the metabolism of [4,5-3H] Using palmitoyl CoA as the fatty-acid donor, dihydroceramide synthesis was stimulated up to 1.5-fold by Mg2", with maximal stimulation at 1 mM (Figure 3 ). Mn2+ stimulated synthesis at low concentrations (0.5 mM), but higher concentrations inhibited synthesis ( Figure 3) ; these results are similar to those obtained using chicken liver microsomes and Tween-20 to dissolve the lipid substrates (Sribney, 1966) . All subsequent assays ofdihydroceramide synthesis were performed in the presence of 2 mM MgCl2.
The Mg2+-stimulated hydrolysis of ceramide to sphingosine has been reported to occur at neutral pH values in rat liver PM (Slife et al., 1989 ) and other tissues (Spence et al., 1986) , using an assay in which lipid substrates were solubilized by detergents. To exclude the possibility that newly synthesized [4,5-3H] [4,5-3H] sphinganine could be recovered together with the membranes in a high-speed pellet (Beckmann airfuge, 100000 g, 10 min), whereas all the sulphorhodamine-conjugated BSA remained in the supernatant (results not shown).
After pre-incubation of microsomes with sphinganine, an aqueous solution of palmitoyl CoA was added to the reaction mixture. Maximal dihydroceramide synthesis was observed only when BSA was present; in cases where BSA was omitted, dihydroceramide synthesis was significantly reduced because of the detergent-like effects of palmitoyl CoA (Richards et al., 1990) . Similar findings have been reported for other palmitoylCoA-utilizing enzymes, including dihydroxyacetonephosphate acyltransferase (Das et al., 1992) . Indeed, incubation of microsomes with 150 ,uM palmitoyl CoA affected microsomal integrity since a significant reduction in the latency of mannose-6-phosphatase was observed, whereas addition of 20,uM BSA together with palmitoyl CoA prevented this effect. The optimum ratio of BSA to palmitoyl CoA was determined to be 1:3-4; higher ratios reduced dihydroceramide synthesis due to the highaffinity binding of palmitoyl CoA to BSA, which reduced the amount of available palmitoyl CoA (Pauly and Distribution of dlhydroceramide synthesis in rat liver membrane fractions Using well-characterized microsomal subfractions (Ehrenreich et al., 1973; Futerman and Pagano, 1991) , the distribution of recovered dihydroceramide synthesis exactly paralleled that of an ER marker, glucose-6-phosphatase, with 92 % ofeach activity obtained in fractions 5 and 6, which consist predominantly of smooth microsomes and rough microsomes respectively. 1991) which contain 50-60% of the Golgi apparatus marker, galactosyhansferase (Table 1) .
Since fractions 5 and 6 also contained significant amounts of the PM marker, alkaline phosphodiesterase, dihydroceramide synthesis was examined in an isolated PM-sheet preparation (Hubbard et al., 1983) . Of the recovered alkaline phosphodiesterase 32 % was obtained in the PM preparation but it only contained 1.5 % of dihydroceramide synthesis (Table 2) . Moreover, all of the dihydroceramide synthesis in the PM preparation could be accounted for as contamination by ER membranes, since 3.7 % of recovered glucose-6-phosphatase was in this fraction. A similar lack of dihydroceramide synthesis by rat liver PM fractions has been reported (Slife et al., 1989) .
Finally, dihydroceramide synthesis was assayed in an intact Golgi apparatus preparation (Bergeron et al., 1982) . No enrichment in distribution or specific activity was found in this fraction (Table 2) confirming that no dihydroceramide synthesis occurs in the Golgi apparatus.
Topology of dihydroceramide synthesis in microsomes The topology of dihydroceramide synthesis was examined by limited proteolytic-digestion of intact and disrupted microsomes.
Conditions were established so that microsomes were not disrupted by proteases, with microsomal integrity remaining at 85-95% after treatment with. either Pronase ( Figure 5 ) or chymotrypsin (results not shown). However, trypsin caused significant disruption of microsomes since mannose-6-phosphatase latency was reduced to 50 % even at a low ratio of trypsin (Morell and Radin, 1970) , it has been assumed that the ER is the site of synthesis of ceramides (see for example Bruning et al., 1992; Kendler and Dawson, 1992) , although there has been no direct evidence to date that synthesis occurs in the ER and not the Golgi apparatus. Therefore, in the present study we have determined the site and topology of dihydroceramide synthesis using well-characterized subcellular fractions in which the ER and Golgi apparatus can be well-separated, and have demonstrated that dihydroceramide is synthesized at the cytosolic surface of the ER in rat liver, with no synthesis occurring in the Golgi apparatus. Similar conclusions concerning the site and topology of dihydroceramide synthesis in mouse liver were reported recently (Mandon et al., 1992) , although no attempts were made to work at saturating concentrations of substrates (see below).
[
4,5-3H]Dihydroceramide synthesis in vitro
In order to analyse dihydroceramide synthesis in vitro, we characterized an assay in which sphinganine was added to membrane fractions by spontaneous transfer from a BSA complex. This is in contrast with various other assays of ceramide synthesis in which the long-chain bases were dissolved in detergents (Sribney, 1966; Mandon et al., 1991) and/or dispersed by sonication (Mandon et al., 1991 (Mandon et al., , 1992 , or coated on Celite (Morell and Radin, 1970; Singh, 1983) . These methods are often problematic since the activity of many integral membrane proteins is affected by detergents or other treatments that disrupt membrane integrity. To compare enzyme activities in different subcellular fractions, it is essential that the substrates are present at saturating concentrations so that the rate of the reaction is directly proportional to the amount of enzyme present in the fractions. We therefore determined conditions in which the rate of formation of dihydroceramide was not limited by availability of either sphinganine or palmitoyl CoA. The rate of the reaction was found to be critically dependent on the ratio of palmitoyl CoA and BSA in the reaction mixture. At low ratios, fatty-acyl CoA bound tightly to BSA and was unavailable for the enzyme reaction (Pauly and McMillin, 1988) thus reducing the apparent concentration of palmitoyl CoA, and at high ratios, palmitoyl CoA acted as a detergent and severely reduced dihydroceramide synthesis, presumably by disrupting membrane integrity or enzyme structure. Thus, although BSA acts as a useful substrate depot for the delivery of acyl units to lipid-metabolizing enzymes in vitro, care must be taken that saturating conditions of fattyacyl CoAs are present (Pauly and McMillin, 1988) . Analysis of sphinganine N-acyltransferase in the absence of BSA using high concentrations of palmitoyl CoA [i.e. 200 ,uM; Wang et al. (1991) ] may lead to an underestimation of enzyme activity.
Metabolic consequences of dihydroceramide synthesis in the ER Sphingolipids contain four kinds of fatty acids, namely saturated long-chain fatty acids, very-long-chain fatty acids, monoenoic fatty acids and a-hydroxy-very-long-chain fatty acids (reviewed in Kishimoto, 1983; Merrill and Jones, 1990) ; the fatty-acyl specificity of sphinganine N-acyltransferase(s) will be determined only when the enzyme has been purified and reconstituted. Once sphinganine has been acylated at the cytosolic surface of the ER (Figure 6 ), dihydroceramide is presumably dehydrogenated to form ceramide, since the predominant form of the long-chain base in sphingolipids is sphingosine, not sphinganine. This putative dehydrogenase has never been observed either in vitro or in vivo. However, it has been suggested that the double bond of sphingolipids may be added in a different subcellular compartment from that in which dihydroceramide is synthesized (Merrill and Wang, 1986 ). An important unresolved issue in sphingolipid biochemistry concerns the identification and subcellular localization of the dehydrogenase (Figure 6 ).
Ceramide is metabolized to GlcCer at the cytosolic surface of a pre-or early Golgi apparatus compartment (Figure 6 ) (Futerman and Pagano, 1991) ; similar conclusions about the topology of GlcCer synthesis have been reached by others although Trinchera et al. (1991) reported that GlcCer synthesis occurs only in the Golgi apparatus, and Jeckel et al. (1992) reported that significant amounts of GlcCer are synthesized in a distal Golgi apparatus compartment. The latter conclusion is based on sucrose-gradient fractionation in which two major peaks of activity of GlcCer synthesis were observed, namely in proximal and distal Golgi apparatus fractions. It should be noted that the putative proximal Golgi apparatus marker used in this study, N-acetylglucosaminylphosphotransferase, has never been unequivocally demonstrated to be located in the proximal Golgi apparatus by immunocytochemical methods.
Ceramide is metabolized to SM at the lumenal surface of the cis and medial Golgi apparatus ( Figure 6 ) (Futerman et al., 1990) or the cis Golgi (Jeckel et al., 1990) . A rate-limiting step in sphingolipid synthesis may be delivery of ceramide from the ER to sites of subsequent metabolism. Support for this idea comes from recent experiments in which brefeldin A led to an increase of SM synthesis in Chinese hamster ovary cells. Brefeldin A causes redistribution of Golgi-associated enzymes to the ER (Klausner et al., 1992) , and the increase of SM synthesis in the presence of brefeldin A was suggested to be due to translocation of SM synthase to the ER, resulting in an increase of the availability ofceramide to SM synthase since the pool ofceramide in the mixed ER-Golgi organelle may be larger than that in the Golgi apparatus alone (Bruning et al., 1992 Two potential mechanisms exist for transporting (dihydro)-ceramide out of the ER. Dihydroceramide might be transported by the same vesicles that transport proteins out of the ER and along the secretory pathway. Evidence that may support this possibility has been provided by studies in Saccharomyces cerevisiae in which the synthesis of mannosylated ceramide derivatives in the Golgi apparatus was dependent upon genes controlling the flow of secretory vesicles from the ER to Golgi apparatus (Puoti et al., 1991) ; however, no data was presented in these studies to definitively locate the enzymes of sphingolipid synthesis in Saccharomyces sp. Alternatively, ceramide may be transported as lipid monomers through the cytosol by proteinfacilitated transport. Interestingly, all four stereoisomers of sphinganine are acylated in vivo, but only the D-erythro and to some extent the L-threo isomers are subsequently converted into SM and GlcCer (Stoffel and Bister, 1973) , perhaps implying that D-erythro-ceramide is transported out of the ER by a proteinfacilitated mechanism that is stereospecific towards the longchain base. Evidence supporting this idea comes from observations that SM synthase is able to metabolize all four ceramide stereoisomers and GlcCer synthase is able to metabolize both Derythro-and L-erythro-ceramide (Pagano and Martin, 1988) . Resolution of the mechanism of transport of (dihydro)ceramide out of the ER awaits isolation of the vesicles responsible for transporting material from the ER to the Golgi apparatus; initial attempts to isolate these transition vesicles indicated that cerebrosides were not significantly enriched (Moreau et al., 1991) . Alternatively, a cell-free assay of lipid flow from the ER to the Golgi apparatus could be established. Our demonstration that the early steps of sphingolipid synthesis are compartmentalized within the ER-Golgi complex, and our characterization of a detergent-free assay for ceramide synthesis that does not effect microsomal integrity, provide the biochemical tools for the establishment of such an assay.
